TY - STD TI - International Diabetes Federation. IDF Diabetes Atlas, 6th edition. Brussels, Belgium; 2013. https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/19-atlas-6th-edition.html. Accessed 6 May 2020. UR - https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/19-atlas-6th-edition.html ID - ref1 ER - TY - JOUR AU - Yau, J. W. AU - Rogers, S. L. AU - Kawasaki, R. AU - Lamoureux, E. L. AU - Kowalski, J. W. AU - Bek, T. PY - 2012 DA - 2012// TI - Global prevalence and major risk factors of diabetic retinopathy JO - Diabetes Care VL - 35 UR - https://doi.org/10.2337/dc11-1909 DO - 10.2337/dc11-1909 ID - Yau2012 ER - TY - JOUR AU - Romero-Aroca, P. PY - 2011 DA - 2011// TI - Managing diabetic macular edema: the leading cause of diabetes blindness JO - World J Diabetes VL - 2 UR - https://doi.org/10.4239/wjd.v2.i6.98 DO - 10.4239/wjd.v2.i6.98 ID - Romero-Aroca2011 ER - TY - JOUR AU - Funatsu, H. AU - Noma, H. AU - Mimura, T. AU - Eguchi, S. AU - Hori, S. PY - 2009 DA - 2009// TI - Association of vitreous inflammatory factors with diabetic macular edema JO - Ophthalmology. VL - 116 UR - https://doi.org/10.1016/j.ophtha.2008.09.037 DO - 10.1016/j.ophtha.2008.09.037 ID - Funatsu2009 ER - TY - JOUR AU - Miyamoto, K. AU - Khosrof, S. AU - Bursell, S. E. AU - Rohan, R. AU - Murata, T. AU - Clermont, A. C. PY - 1999 DA - 1999// TI - Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition JO - Proc Natl Acad Sci U S A VL - 96 UR - https://doi.org/10.1073/pnas.96.19.10836 DO - 10.1073/pnas.96.19.10836 ID - Miyamoto1999 ER - TY - JOUR AU - Bhagat, N. AU - Grigorian, R. A. AU - Tutela, A. AU - Zarbin, M. A. PY - 2009 DA - 2009// TI - Diabetic macular edema: pathogenesis and treatment JO - Surv Ophthalmol VL - 54 UR - https://doi.org/10.1016/j.survophthal.2008.10.001 DO - 10.1016/j.survophthal.2008.10.001 ID - Bhagat2009 ER - TY - JOUR AU - Park, Y. G. AU - Kim, E. Y. AU - Roh, Y. J. PY - 2014 DA - 2014// TI - Laser-based strategies to treat diabetic macular edema: history and new promising therapies JO - J Ophthalmol VL - 2014 UR - https://doi.org/10.1155/2014/769213 DO - 10.1155/2014/769213 ID - Park2014 ER - TY - STD TI - American Academy of Ophthalmology. Diabetic Retinopathy Preferred Practice Pattern [https://www.aao.org/preferred-practice-pattern/diabetic-retinopathy-ppp] Accessed 6 May 2020. UR - https://www.aao.org/preferred-practice-pattern/diabetic-retinopathy-ppp ID - ref8 ER - TY - JOUR AU - Pahor, D. PY - 1998 DA - 1998// TI - Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: full- versus mild-scatter coagulation JO - Int Ophthalmol VL - 22 UR - https://doi.org/10.1023/A:1006367029134 DO - 10.1023/A:1006367029134 ID - Pahor1998 ER - TY - JOUR AU - Rechtman, E. AU - Harris, A. AU - Garzozi, H. J. AU - Ciulla, T. A. PY - 2007 DA - 2007// TI - Pharmacologic therapies for diabetic retinopathy and diabetic macular edema JO - Clin Ophthalmol VL - 1 ID - Rechtman2007 ER - TY - JOUR AU - Nguyen, Q. D. AU - Shah, S. M. AU - Khwaja, A. A. AU - Channa, R. AU - Hatef, E. AU - Do, D. V. PY - 2010 DA - 2010// TI - Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study JO - Ophthalmology. VL - 117 UR - https://doi.org/10.1016/j.ophtha.2010.08.016 DO - 10.1016/j.ophtha.2010.08.016 ID - Nguyen2010 ER - TY - JOUR AU - Wang, K. AU - Wang, Y. AU - Gao, L. AU - Li, X. AU - Li, M. AU - Guo, J. PY - 2008 DA - 2008// TI - Dexamethasone inhibits leukocyte accumulation and vascular permeability in retina of streptozotocin-induced diabetic rats via reducing vascular endothelial growth factor and intercellular adhesion molecule-1 expression JO - Biol Pharm Bull VL - 31 UR - https://doi.org/10.1248/bpb.31.1541 DO - 10.1248/bpb.31.1541 ID - Wang2008 ER - TY - STD TI - Tamura H, Miyamoto K, Kiryu J, Miyahara S, Katsuta H, Hirose F, et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci 2005;46(4):1440–4. ID - ref13 ER - TY - JOUR AU - Antonetti, D. A. AU - Wolpert, E. B. AU - DeMaio, L. AU - Harhaj, N. S. AU - Scaduto, R. C. PY - 2002 DA - 2002// TI - Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin JO - J Neurochem VL - 80 UR - https://doi.org/10.1046/j.0022-3042.2001.00740.x DO - 10.1046/j.0022-3042.2001.00740.x ID - Antonetti2002 ER - TY - JOUR AU - Boyer, D. S. AU - Yoon, Y. H. AU - Belfort, R. AU - Bandello, F. AU - Maturi, R. K. AU - Augustin, A. J. PY - 2014 DA - 2014// TI - Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema JO - Ophthalmology. VL - 121 UR - https://doi.org/10.1016/j.ophtha.2014.04.024 DO - 10.1016/j.ophtha.2014.04.024 ID - Boyer2014 ER - TY - JOUR AU - Korobelnik, J. F. AU - Kodjikian, L. AU - Delcourt, C. AU - Gualino, V. AU - Leaback, R. AU - Pinchinat, S. PY - 2016 DA - 2016// TI - Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France JO - Graefes Arch Clin Exp Ophthalmol VL - 254 UR - https://doi.org/10.1007/s00417-016-3394-y DO - 10.1007/s00417-016-3394-y ID - Korobelnik2016 ER - TY - STD TI - Indian Council of Medical Research. National Ethical Guidelines for Biomedical and Health Research Involving Human Participants. [http://ethics.ncdirindia.org//asset/pdf/ICMR_National_Ethical_Guidelines.pdf] Accessed 6 May 2020. UR - http://ethics.ncdirindia.org//asset/pdf/ICMR_National_Ethical_Guidelines.pdf ID - ref17 ER - TY - STD TI - Ministry of Health and Family Welfare. Drugs and Cosmetics (2nd Amendment) Rules [Available at: http://drugs.kar.nic.in/sites/drugs.kar.nic.in/files/topimages/Schedule_Y.pdf] Accessed 6 May 2020. UR - http://drugs.kar.nic.in/sites/drugs.kar.nic.in/files/topimages/Schedule_Y.pdf ID - ref18 ER - TY - JOUR AU - Malclès, A. AU - Dot, C. AU - Voirin, N. AU - Agard, É. AU - Vié, A. L. AU - Bellocq, D. PY - 2017 DA - 2017// TI - Real-life study in diabetic macular edema treated with dexamethasone implant: the Reldex study JO - Retina. VL - 37 UR - https://doi.org/10.1097/IAE.0000000000001234 DO - 10.1097/IAE.0000000000001234 ID - Malclès2017 ER - TY - JOUR AU - Capone, A. AU - Singer, M. A. AU - Dodwell, D. G. AU - Dreyer, R. F. AU - Oh, K. T. AU - Roth, D. B. PY - 2014 DA - 2014// TI - Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study) JO - Retina. VL - 34 UR - https://doi.org/10.1097/IAE.0b013e318297f842 DO - 10.1097/IAE.0b013e318297f842 ID - Capone2014 ER - TY - JOUR AU - Khurana, R. N. AU - Bansal, A. S. AU - Chang, L. K. AU - Palmer, J. D. AU - Wu, C. AU - Wieland, M. R. PY - 2017 DA - 2017// TI - Prospective evaluation of a sustained-release dexamethasone intravitreal implant for cystoid macular edema in quiescent uveitis JO - Retina. VL - 37 UR - https://doi.org/10.1097/IAE.0000000000001406 DO - 10.1097/IAE.0000000000001406 ID - Khurana2017 ER - TY - JOUR AU - Barteselli, G. AU - Amini, P. AU - Ezon, I. AU - Nezgoda, J. AU - Cheng, L. AU - Freeman, W. PY - 2015 DA - 2015// TI - Impact on intraocular pressure after 20-mg decanted triamcinolone acetonide (Kenalog) injection when utilizing prophylactic antiglaucoma therapy JO - Retina. VL - 35 UR - https://doi.org/10.1097/IAE.0000000000000268 DO - 10.1097/IAE.0000000000000268 ID - Barteselli2015 ER - TY - JOUR AU - Bozkurt, E. AU - Kara, N. AU - Yazici, A. AU - Yuksel, K. AU - Demirok, A. AU - Yilmaz, O. PY - 2011 DA - 2011// TI - Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection JO - Am J Ophthalmol VL - 152 UR - https://doi.org/10.1016/j.ajo.2011.05.027 DO - 10.1016/j.ajo.2011.05.027 ID - Bozkurt2011 ER - TY - JOUR AU - Han, J. B. AU - Seo, K. H. AU - Yu, S. Y. PY - 2014 DA - 2014// TI - The effect of prophylactic IOP-lowering medication after intravitreal dexamethasone implantation JO - J Korean Ophthalmol Soc VL - 55 UR - https://doi.org/10.3341/jkos.2014.55.12.1828 DO - 10.3341/jkos.2014.55.12.1828 ID - Han2014 ER - TY - JOUR AU - Malclès, A. AU - Dot, C. AU - Voirin, N. AU - Vié, A. AU - Agard, É. AU - Bellocq, D. PY - 2017 DA - 2017// TI - Safety of intravitreal dexamethasone implant (Ozurdex): the SAFODEX study. Incidence and risk factors of ocular hypertension JO - Retina. VL - 37 UR - https://doi.org/10.1097/IAE.0000000000001369 DO - 10.1097/IAE.0000000000001369 ID - Malclès2017 ER -